Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patients

…, H Schrezenmeier, C Ludwig, A Sattler, K Kotsch… - Science …, 2021 - science.org
Patients with kidney failure are at increased risk of SARS-CoV-2 infection, making effective
vaccinations a critical need. It is not known how well mRNA vaccines induce B and plasma …

[HTML][HTML] Multiplexed histology analyses for the phenotypic and spatial characterization of human innate lymphoid cells

…, R Uecker, K Holzwarth, K Kotsch… - Nature …, 2021 - nature.com
Innate lymphoid cells (ILCs) emerge in the last few years as important regulators of immune
responses and biological processes. Although ILCs are mainly known as tissue-resident …

Abnormal T-cell reactivity against paternal antigens in spontaneous abortion: adoptive transfer of pregnancy-induced CD4+ CD25+ T regulatory cells prevents fetal …

…, A Sollwedel, AZ Bertoja, T Ritter, K Kotsch… - The American journal of …, 2005 - Elsevier
Mammalian pregnancy is thought to be a state of immunological tolerance. The mechanisms
underlying this phenomenon are still poorly understood. Here, we determined whether an …

[HTML][HTML] Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients

…, M Choi, F Halleck, K Kotsch - The Journal of …, 2021 - Am Soc Clin Investig
Novel mRNA-based vaccines have been proven to be powerful tools in combating the global
pandemic caused by SARS-CoV-2, with BNT162b2 (trade name: Comirnaty) efficiently …

Quantitative DNA Methylation Analysis of FOXP3 as a New Method for Counting Regulatory T Cells in Peripheral Blood and Solid Tissue

…, S Floess, V Liebenberg, U Baron, D Stauch, K Kotsch… - Cancer research, 2009 - AACR
Regulatory T-cells (Treg) have been the focus of immunologic research due to their role in
establishing tolerance for harmless antigens versus allowing immune responses against foes. …

[HTML][HTML] SARS–CoV-2–specific T cell responses and correlations with COVID-19 patient predisposition

…, F Halleck, ME Kreis, K Kotsch - The Journal of …, 2020 - Am Soc Clin Investig
Coronavirus disease 2019 (COVID-19) has emerged as a global pandemic caused by severe
acute respiratory syndrome coronavirus 2 (SARS–CoV-2). So far, viral targets of cellular …

Methylprednisolone therapy in deceased donors reduces inflammation in the donor liver and improves outcome after liver transplantation: a prospective randomized …

K Kotsch, F Ulrich, A Reutzel-Selke, A Pascher… - Annals of …, 2008 - journals.lww.com
Objective: To investigate potential beneficial effects of donor treatment with methylprednisolone
on organ function and outcome after liver transplantation. Summary Background Data: It …

[HTML][HTML] Temporary antimetabolite treatment hold boosts SARS-CoV-2 vaccination–specific humoral and cellular immunity in kidney transplant recipients

…, B Jahrsdörfer, KU Eckardt, N Lachmann, K Kotsch… - JCI insight, 2022 - ncbi.nlm.nih.gov
Transplant recipients exhibit an impaired protective immunity after SARS-CoV-2 vaccination,
potentially caused by mycophenolate (MPA) immunosuppression. Recent data from …

Heme oxygenase‐1 inhibits rat and human breast cancer cell proliferation: mutual cross inhibition with indoleamine 2, 3‐dioxygenase

…, R Brion, K Ashgar, MF Mashreghi, K Kotsch… - The FASEB …, 2005 - Wiley Online Library
Heme oxygenase‐1 (HO‐1) is the rate limiting enzyme of heme catabolism whereas
indoleamine 2,3 dioxygenase (IDO) catabolizes tryptophan through the kynurenine pathway. We …

[HTML][HTML] B Cell Numbers Predict Humoral and Cellular Response Upon SARS–CoV‐2 Vaccination Among Patients Treated With Rituximab

…, C Ludwig, A Sattler, K Kotsch… - Arthritis & …, 2022 - Wiley Online Library
Objective Patients with autoimmune inflammatory rheumatic diseases receiving rituximab (RTX)
therapy are at higher risk of poor COVID‐19 outcomes and show substantially impaired …